Healthcare & Life Sciences
MediLink Therapeutics
MediLink Therapeutics is a Healthcare & Life Sciences startup based in China, most recent round Series B, 2 tracked investors.
Activeseries-b
series-b
Stage
2020
Founded
2
Investors
About MediLink Therapeutics
Based in China, MediLink Therapeutics is a startup founded in 2020. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
The startup develops conjugated drugs using its proprietary ADC technology.
Explore MediLink Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.